Stada Takes ViruProtect Cold Spray To Vietnam, Launches Austria’s First OTC Triptan
Executive Summary
Stada Arzneimittel is expanding its presence in Vietnam's $2.4bn OTC market and launching Austria's first non-prescription triptan.
You may also be interested in...
People On The Move: Appointments At GSK, Enzymatica And ANSES
The latest European consumer health industry appointments: GSK names Southern Europe head and adds media chief; Enzymatica's new CEO makes early start; and France's ANSES hires risk assessment director.
Sanofi Streamlines European Portfolio With Brand Sale To Stada
Sanofi is pressing ahead with plans to divest up to 150 consumer health brands by selling a portfolio of 16 products marketed in key European countries to Germany's Stada.
People On The Move: Appointments At Stada, CHPA, Valbiotis And DSA
The latest global health and wellness industry appointments: Stada hires Uriach's Roura to lead Spanish OTC business; CHPA elects J&J's Goodridge; Valbiotis brings in Ipsen's Bessy; and Mannatech's Bala joins DSA's board.